Validation of baicalein and oridonin as nonspecific SARS-CoV-2 main protease inhibitors

被引：2
|
作者：
Yan, Haohao [1 ]
Zhang, Rui [1 ]
Yan, Gangan [1 ]
Liu, Xiaoping [1 ]
Li, Ni [2 ]
Chen, Yunyu [1 ]
机构：
[1] Wannan Med Coll, Inst Drug Screening & Evaluat, Wuhu 241002, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing 100050, Peoples R China
来源：
PHYTOTHERAPY RESEARCH | 2024年 / 38卷 / 03期
基金：
中国国家自然科学基金;
关键词：
D O I：
10.1002/ptr.7829
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
引用
收藏
页码：1161 / 1164
页数：4
相关论文
共 50 条
  • [21] Statine-based peptidomimetic compounds as inhibitors for SARS-CoV-2 main protease (SARS-CoV-2 Mpro)
    Azevedo, Pedro Henrique R. de A.
    Camargo, Priscila G.
    Constant, Larissa E. C.
    Costa, Stephany da S.
    Silva, Celimar Sinezia
    Rosa, Alice S.
    Souza, Daniel D. C.
    Tucci, Amanda R.
    Ferreira, Vivian N. S.
    Oliveira, Thamara Kelcya F.
    Borba, Nathalia R. R.
    Rodrigues, Carlos R.
    Albuquerque, Magaly G.
    Dias, Luiza R. S.
    Garrett, Rafael
    Miranda, Milene D.
    Allonso, Diego
    Lima, Camilo Henrique da S.
    Muri, Estela Maris F.
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [22] SARS-CoV-2 Main Protease as Target
    不详
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 (06) : 1278 - 1278
  • [23] Repurposing of renin inhibitors as SARS-COV-2 main protease inhibitors: A computational study
    Refaey, Rana H.
    El-Ashrey, Mohamed K.
    Nissan, Yassin M.
    VIROLOGY, 2021, 554 : 48 - 54
  • [24] Potential Self-Peptide Inhibitors of the SARS-CoV-2 Main Protease
    Banerjee, Arkadeep
    Gosavi, Shachi
    JOURNAL OF PHYSICAL CHEMISTRY B, 2023, 127 (04): : 855 - 865
  • [25] Triterpenic Acid Amides as Potential Inhibitors of the SARS-CoV-2 Main Protease
    Baev, Dmitry S.
    Blokhin, Mikhail E.
    Chirkova, Varvara Yu.
    Belenkaya, Svetlana V.
    Luzina, Olga A.
    Yarovaya, Olga I.
    Salakhutdinov, Nariman F.
    Shcherbakov, Dmitry N.
    MOLECULES, 2023, 28 (01):
  • [26] Azapeptides with unique covalent warheads as SARS-CoV-2 main protease inhibitors
    Khatua, Kaustav
    Alugubelli, Yugendar R.
    Yang, Kai S.
    Vulupala, Veerabhadra R.
    Blankenship, Lauren R.
    Coleman, Demonta
    Atla, Sandeep
    Chaki, Sankar P.
    Geng, Zhi Zachary
    Xiao, Jing
    Chen, Peng-Hsun
    Cho, Chia-Chuan D.
    Sharma, Shivangi
    Vatansever, Erol C.
    Ma, Yuying
    Yu, Ge
    Neuman, Benjamin W.
    Xu, Shiqing
    Liu, Wenshe Ray
    ANTIVIRAL RESEARCH, 2024, 225
  • [27] Search of Novel Small Molecule Inhibitors for the Main Protease of SARS-CoV-2
    Zhang, Wenfa
    Lin, Sheng-Xiang
    VIRUSES-BASEL, 2023, 15 (02):
  • [28] In Silico Identification of Potential Inhibitors of SARS-CoV-2 Main Protease (Mpro)
    Hernandez-Serda, Manuel Alejandro
    Vazquez-Valadez, Victor H.
    Aguirre-Vidal, Pablo
    Markarian, Nathan M.
    Medina-Franco, Jose L.
    Cardenas-Granados, Luis Alfonso
    Alarcon-Lopez, Aldo Yoshio
    Martinez-Soriano, Pablo A.
    Velazquez-Sanchez, Ana Maria
    Falfan-Valencia, Rodolfo E.
    Angeles, Enrique
    Abrahamyan, Levon
    PATHOGENS, 2024, 13 (10):
  • [29] Design of novel and highly selective SARS-CoV-2 main protease inhibitors
    Poli, Adi N. R.
    Tietjen, Ian
    Nandwana, Nitesh K.
    Cassel, Joel
    Messick, Troy E.
    Register, Emery T.
    Keeney, Frederick
    Rajaiah, Rajesh
    Verma, Atul K.
    Pandey, Kabita
    Acharya, Arpan
    Byrareddy, Siddappa N.
    Montaner, Luis J.
    Salvino, Joseph M.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2024, 68 (10)
  • [30] Molecular Docking Unveils Prospective Inhibitors for the SARS-COV-2 Main Protease
    Ahmad, Fawad
    Ikram, Saima
    Ahmad, Jamshaid
    Rehman, Irshad Ur
    Khattak, Saeed Ullah
    Butt, Sadia
    Mushtaq, Maryam
    SAINS MALAYSIANA, 2021, 50 (05): : 1473 - 1484
12345